A new study on aortic stenosis, the most common form of heart valve disease, has identified more than 200 new genes that predispose individuals to this condition, for which no treatment currently exists. The discovery of these genes, some of which are also associated with faster disease progression, could make it possible to identify individuals at high risk of developing the disease, with a view to offering them earlier intervention. It also opens new avenues into treatments aiming to slow or stop the progression of the disease.
This article was originally published on MedicalXpress.com
